Biomedical subjects

Ing-Ming Hwang

Publications and source records attributed to Ing-Ming Hwang.

6 recordsLinked to original sources

PubMed2005

Scatter correction for 3D PET using beam stoppers combined with dual-energy window acquisition: a feasibility study.

Fully three-dimensional (3D) positron emission tomography (PET) can achieve high sensitivity of coincidence events, but the absence of inter-slice septa inevitably leads to increased scattered events. The scattered events can represent as much as 50% of the total detected events. In this research, we proposed a scatter correction method for 3D PET based on beam stoppers and dual-energy window acquisition. The beam stoppers were placed surrounding the object to attenuate primary beams. The scatter fractions were directly estimated at those blocked lines of response and then the entire scatter fraction distribution was recovered using the dual-energy window ratio as reference. The performance was evaluated by using Monte Carlo simulations of various digital phantoms. For the Utah phantom study, the proposed method accurately estimated the scatter fraction distribution, and improved image contrast and quantification based on four different quality indices as performance measures. For the non-homogeneous Zubal phantom, the simulated results also demonstrated that the proposed method achieved a better restoration of image contrast than the dual-energy window method. We conclude that the proposed scatter correction method could effectively suppress various kinds of scattered events, including multiple scatter and scatter from outside the field of view.

Computer Simulation↗

PubMed2004

Antisense thymidylate synthase electrogene transfer to increase uptake of radiolabeled iododeoxyuridine in a murine model.

UNLABELLED: In vitro and in vivo experiments from our laboratory and others have suggested that the combination of thymidylate synthase (TS) inhibitor and radiolabeled iododeoxyuridine (IdUrd) is synergistic. Efficacy is limited by drug resistance, which is often mediated by TS overexpression. We designed an in vivo electrogene transfer (EGT) model for delivering antisense TS plasmid (ATS) into tumor to increase the subsequent efficacy of (131)I-IdUrd therapy. METHODS: Plasmid complementary to nucleotide 531-710 in the coding region of the mouse TS (mTS) mRNA was constructed. TS activity and (131)I-IdUrd DNA incorporation were determined 48 h after in vitro EGT of ATS to CT26 cells. In vivo therapeutic effect and radioactivity retained in tumor after various combinations of EGT ATS, 5-fluorouracil (5-FU), and continuous infusion of (131)I-IdUrd by osmotic minipump were determined. RESULTS: A reduction of TS activity was achieved after in vitro EGT ATS. Flow cytometry analysis indicated that ATS-treated cells were arrested at S phase. In the in vivo tumor model, the combination of EGT ATS and 5-FU was able to partially overcome 5-FU drug resistance. Sixty percent of tumors can be eradicated by the combination of EGT ATS, 5-FU, and infusion of (131)I-IdUrd. The tumors treated by EGT ATS had higher radioactivity retained 1 wk after (131)I-IdUrd therapy than after EGT of control plasmid. CONCLUSION: In situ EGT ATS can downregulate TS and increase the therapeutic effect of radiolabeled IdUrd therapy. The combination of EGT ATS, 5-FU, and (131)I-IdUrd may result in tumor eradication.

Adenocarcinoma↗

PubMed2003

Quality degradation in lossy wavelet image compression.

The objective of this study was to develop a method for measuring quality degradation in lossy wavelet image compression. Quality degradation is due to denoising and edge blurring effects that cause smoothness in the compressed image. The peak Moran z histogram ratio between the reconstructed and original images is used as an index for degradation after image compression. The Moran test is applied to images randomly selected from each medical modality, computerized tomography, magnetic resonance imaging, and computed radiography and compressed using the wavelet compression at various levels. The relationship between the quality degradation and compression ratio for each image modality agrees with previous reports that showed a preference for mildly compressed images. Preliminary results show that the peak Moran z histogram ratio can be used to quantify the quality degradation in lossy image compression. The potential for this method is applications for determining the optimal compression ratio (the maximized compression without seriously degrading image quality) of an image for teleradiology.

Diagnostic Imaging↗

PubMed2003

A novel image quality index using Moran I statistics.

Measurement of image quality is very important for various applications such as image compression, restoration and enhancement. Conventional methods (e.g., mean squared error; MSE) use error summation to measure quality change pixel by pixel and do not correlate well with subjective quality measurement. This is due to the fact that human eyes extract structural information from the viewing field. In this study a new quality index using a Moran I statistics is proposed. The Moran statistic that measures the sharpness from a local area is a good index of quality as most image processing techniques alter the smoothness of the image. Preliminary results show that the new quality index outperforms the MSE significantly under various types of image distortions.

Algorithms↗

PubMed2003

Determination of beam intensity in a single step for IMRT inverse planning.

In intensity modulated radiotherapy (IMRT), targets are treated by multiple beams at different orientations each with spatially-modulated beam intensities. This approach spreads the normal tissue dose to a greater volume and produces a higher dose conformation to the target. In general, inverse planning is used for IMRT treatment planning. The inverse planning requires iterative calculation of dose distribution in order to optimize the intensity profile for each beam and is very computation intensive. In this paper, we propose a single-step method utilizing a figure of merit (FoM) to estimate the beam intensities for IMRT treatment planning. The FoM of a ray is defined as the ratio between the delivered tumour dose and normal tissue dose and is a good index for the dose efficacy of the ray. To maximize the beam utility, it is natural to irradiate the tumour with intensity of each ray proportional to the value of the FoM. The nonuniform beam intensity profiles are then fixed and the weights of the beam are determined iteratively in order to yield a uniform tumour dose. In this study, beams are employed at equispaced angles around the patient. Each beam with its field size that just covers the tumour is divided into a fixed number of beamlets. The FoM is calculated for each beamlet and this value is assigned to be the beam intensity. Various weighting factors are incorporated in the FoM computation to accommodate different clinical considerations. Two clinical datasets are used to test the feasibility of the algorithm. The resultant dose-volume histograms of this method are presented and compared to that of conformal therapy. Preliminary results indicate that this method reduces the critical organ doses at a small expense of uniformity in tumour dose distribution. This method estimates the beam intensity in one single step and the computation time is extremely fast and can be finished in less than one minute using a regular PC.

Algorithms↗

PubMed2002

Comprehensive measurement for clinical dosimetry of tertiary multileaf collimator.

To initiate the use of a tertiary multileaf collimator (MLC) in the clinic, a set of dosimetry data for clinical use of the MLC, the secondary field size jaw and the MLC tracked by the jaw were measured. The dose calculation technique from the commissioned jaw field data was established. The dosimetry characteristics included absolute output (Dw), collimator scatter factor (Sc), total scatter factor (Scp), phantom scatter factor (Sp), percentage depth dose (PDD), tissue-maximum ratio (TMR), and peak scatter factor (PSF). The absolute output of the MLC field was +5% to +2% greater than that of the same jaw size field from 4 x 4 to 24 x 24 cm2 fields. The variation of Sc and Scp ranged from 4 x 4 to 24 x 24 cm2 fields and were less than that of the jaw fields, while the Sp, PDD and TMR values remained the same. Importantly, when the MLC-only field was performed without the collimator jaws tracking close to the field segments, greater output was delivered, and PSFs should be used to calculate the MLC field output.

Humans↗